Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Lasers can help reduce skin side effects from cancer treatment.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Dermatologists should guide patients on blood donation timing due to various eligibility criteria.

Skin ulcers from interferon may not depend on the amount given.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The patient improved after antiviral treatment for a viral infection.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

The FDA approved a new Pfizer drug for hair loss in teens.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

The biofilm enhances skin healing by promoting cell growth and blood vessel formation.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

The man's skin condition improved with sun protection and topical steroids, but UV exposure still caused flare-ups.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Liposomes and iontophoresis effectively deliver protective enzymes into the skin against UV damage.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.